famotidine
Stories
-
FDA determines PEPCID RPD famotidine tablets not withdrawn for safety or effectiveness
The agency decided that the 20 mg and 40 mg orally disintegrating tablets were not removed from sale. This determination will allow FDA to approve abbreviated new drug applications for these products if all other legal and regulatory requirements are met.